Product Image

Contributor Information

  • Name Lindy Durrant
  • Institute University of Nottingham

Tool Details

  • Tool name: Anti-MUC2 [994/152]
  • Clone: 994/152
  • Tool type: Antibodies
  • Tool sub-type: Primary antibody
  • Class: Monoclonal
  • Conjugate: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Cancer type: Digestive / Gastrointestinal cancer;
  • Application: IHC ; ELISA ; IHC
  • Description: Mucins are a family of highly glycosylated, large molecular weight glycoproteins which are associated with many epithelial cells. MUC2 is the major intestinal mucin. O-glycans are attached to MUC2 in a potentially diverse arrangement, which is crucial for their interaction with endogenous and exogenous lectins.
  • Immunogen: A peptide based on the tandem repeat sequence of MUC2
  • Isotype: IgG1
  • Research area: Cancer; Cell biology; Cell signaling and signal transduction
  • Myeloma used: NS0

  • For Research Use Only

Target Details

  • Target: Mucin2 (MUC2)
  • Target background: Mucins are a family of highly glycosylated, large molecular weight glycoproteins which are associated with many epithelial cells. MUC2 is the major intestinal mucin. O-glycans are attached to MUC2 in a potentially diverse arrangement, which is crucial for their interaction with endogenous and exogenous lectins.

Application Details

  • Application: IHC ; ELISA ; IHC

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15°C to -25°C
  • Shipping conditions: Shipping at 4°C

Documentation

References

  •   Gold et al. 2013. Mol Cancer. 12(1):143. PMID: 24257318.
  •   Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin.
  •   Durrant et al. 1994. Eur J Cancer. 30A(3):355-63. PMID: 8204359.
  •   Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin.